ArticleBMJ open2025

Study protocol of the multicentre, randomised, triple-blind, placebo-controlled MERCURI-2 trial: promoting effective renoprotection in cardiac surgery patients by inhibition of sodium glucose cotransporter (SGLT)-2.

Maartina Oosterom-Eijmael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.